HomeNAV • CVE
add
Navco Pharmaceuticals Inc
Previous close
$0.010
Year range
$0.010 - $0.12
Market cap
570.70K CAD
Avg Volume
91.52K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 157.54K | -70.66% |
Net income | -177.47K | 94.69% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -126.14K | 76.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.21K | -98.45% |
Total assets | 951.32K | -27.21% |
Total liabilities | 931.44K | 35.90% |
Total equity | 19.88K | — |
Shares outstanding | 57.07M | — |
Price to book | ∞ | — |
Return on assets | -39.63% | — |
Return on capital | -45.98% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -177.47K | 94.69% |
Cash from operations | -25.28K | 98.13% |
Cash from investing | — | — |
Cash from financing | 15.01K | -97.15% |
Net change in cash | -10.28K | 98.76% |
Free cash flow | -15.89K | — |
About
Headquarters
Website
